Results 61 to 70 of about 367,353 (219)

Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma [PDF]

Modern Pathology, 2014
Clear cell papillary renal cell carcinoma is a distinct variant of renal cell carcinoma that shares some overlapping histological and immunohistochemical features of clear cell renal cell carcinoma and papillary renal cell carcinoma. Although the clear cell papillary renal cell carcinoma immunohistochemical profile is well described, clear cell ...
Kevin E, Fisher, Qiqin, Yin-Goen, Dianne, Alexis, Joseph S, Sirintrapun, William, Harrison, R, Benjamin Isett, Michael R, Rossi, Carlos S, Moreno, Andrew N, Young, Adeboye O, Osunkoya   +9 more
openaire   +2 more sources

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.

European Urology, 2023
CONTEXT Dramatic gains in our understanding of the molecular biology of clear cell renal cell carcinoma (ccRCC) have created a foundation for clinical translation to improve patient care.
B. Cotta, T. Choueiri, M. Cieslik, P. Ghatalia, R. Mehra, T. Morgan, G. Palapattu, B. Shuch, U. Vaishampayan, E. V. Van Allen, A. Ari Hakimi, S. Salami   +11 more
semanticscholar   +1 more source

Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma [PDF]

, 2017
The most common subtype of renal cell carcinoma (RCC) is clear cell RCC (ccRCC). It accounts for 70-80% of all renal malignancies representing the third most common urological cancer after prostate and bladder cancer.
Carbone, Antonio, Costantini, Manuela, DI CARLO, Angelina, Fazi, Francesco, Gallucci, Michele, Marigliano, Chiara, Palleschi, Giovanni, Pastore, ANTONIO LUIGI, Petrozza, Vincenzo, Porta, Natale, Ricci, Serena, Simone, Giuseppe, Tito, Claudia   +12 more
core   +2 more sources

Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma

Cells, 2023
The most common subtype of renal cell carcinoma is clear cell renal cell carcinoma (ccRCC). While localized ccRCC can be cured with surgery, metastatic disease has a poor prognosis. Recently, immunotherapy has emerged as a promising approach for advanced
Lingbin Meng, K. Collier, Peng Wang, Zihai Li, P. Monk, Amir Mortazavi, Zhiwei Hu, Daniel J. Spakowicz, Linghua Zheng, Y. Yang   +9 more
semanticscholar   +1 more source

Relationship between miR‐155 expression and clear cell papillary renal cell carcinoma in the dialyzed kidney

IJU Case Reports, 2021
Introduction Clear cell papillary renal cell carcinoma often develops in the context of the dialyzed kidney (end‐stage renal disease). However, the relationship between clear cell papillary renal cell carcinoma and microRNA expression in patients with ...
Ei Shiomi, Renpei Kato, Tomohiko Matsuura, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Jun Sugimura, Kazuyuki Ishida, Takaya Abe, Tamotsu Sugai, Wataru Obara   +11 more
doaj   +1 more source

Chromophobe Renal Cell Carcinoma [PDF]

, 2013
Renal cell carcinoma is the most common neoplasm of the kidney comprised of different histological variants. Chromophobe renal cell carcinoma (ChRCC) is a rare subtype of renal cell carcinoma (RCC) mainly diagnosed in the sixth decade of life.
Huddedar, AD, Khatib, WGM, Kumbhar, SS, Wader, JV   +3 more
core   +1 more source

Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms. [PDF]

, 2014
Losses in the succinate dehydrogenase (SDH) complex characterize 20% to 30% of extra-adrenal paragangliomas and 7% to 8% of gastric GISTs, and rare renal cell carcinomas.
Biernat, Wojciech, Czapiewski, Piotr, Langfort, Renata, Lasota, Jerzy, McCue, Peter, Miettinen, Markku, Sarlomo-Rikala, Maarit, Waloszczyk, Piotr, Wang, Zengfeng, Wazny, Krzysztof   +9 more
core   +1 more source

Characterization of renal artery variation in patients with clear cell renal cell carcinoma and the predictive value of accessory renal artery in pathological grading of renal cell carcinoma: a retrospective and observational study

BMC Cancer, 2023
Objective To explore the characteristics of renal artery variation in patients with renal cell carcinoma and to evaluate the predicting value of accessory renal artery in the pathological grading of renal cell carcinoma.
Dingyang Lv, Huiyu Zhou, Fan Cui, Jie Wen, Weibing Shuang   +4 more
doaj   +1 more source

Fructose transporter Glut5 expression in clear renal cell carcinoma [PDF]

, 2010
[Abstract] Renal cell carcinomas (RCC) can be subclassified for general purposes into clear cell, papillary cell, chromophobe cell carcinomas and oncocytomas.
Antón-Aparicio, Luis M., Aparicio Gallego, Guadalupe, Bolós Fernández, Victoria, García Campelo, R., Grande Pulido, Enrique, Medina Villaamil, Vanessa, Santamarina, Isabel, Valbuena Ruvira, L., Valladares-Ayerbes, Manuel   +8 more
core   +2 more sources

HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice

Nature Communications, 2020
Mutational inactivation of VHL is the earliest genetic event in the majority of clear cell renal cell carcinomas (ccRCC), leading to accumulation of the HIF-1α and HIF-2α transcription factors.
Rouven Hoefflin, Sabine Harlander, S. Schäfer, Patrick Metzger, F. Kuo, Désirée Schönenberger, Mojca Adlesic, Asin Peighambari, Philipp Seidel, Chia-yi Chen, Miguel Consenza-Contreras, A. Jud, B. Lahrmann, N. Grabe, Danijela Heide, F. Uhl, T. Chan, J. Duyster, R. Zeiser, C. Schell, M. Heikenwalder, Oliver Schilling, Oliver Schilling, A. Hakimi, M. Boerries, M. Boerries, I. Frew   +26 more
semanticscholar   +1 more source